Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The price of Core Scientific Inc (NASDAQ: CORZ) closed at $17.25 in the last session, up 1.05% from day before closing price of $17.07. In other words, the price has increased by $1.05 from its previous closing price. On the day, 16.82 million shares were traded. CORZ stock price reached its highest trading level at $17.58 during the session, while it also had its lowest trading level at $16.57.
Ratios:
We take a closer look at CORZ’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.26 and its Current Ratio is at 4.26.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citizens JMP on May 22, 2025, initiated with a Mkt Outperform rating and assigned the stock a target price of $15.
On January 27, 2025, Keefe Bruyette started tracking the stock assigning a Outperform rating and target price of $22.
On January 21, 2025, Craig Hallum started tracking the stock assigning a Buy rating and target price of $24.Craig Hallum initiated its Buy rating on January 21, 2025, with a $24 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 25 ’25 when DUCHENE TODD M sold 7,759 shares for $12.39 per share. The transaction valued at 96,142 led to the insider holds 2,049,689 shares of the business.
DUCHENE TODD M bought 7,759 shares of CORZ for $96,142 on Jun 25 ’25. On Jun 06 ’25, another insider, Becker Todd A, who serves as the Former Director of the company, bought 195,687 shares for $12.28 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CORZ now has a Market Capitalization of 5137430016 and an Enterprise Value of 5580031488. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.50. Its current Enterprise Value per Revenue stands at 13.58 whereas that against EBITDA is -374.474.
Stock Price History:
The Beta on a monthly basis for CORZ is 6.74, which has changed by 0.7045455 over the last 52 weeks, in comparison to a change of 0.11937654 over the same period for the S&P500. Over the past 52 weeks, CORZ has reached a high of $18.63, while it has fallen to a 52-week low of $6.20. The 50-Day Moving Average of the stock is 58.29%, while the 200-Day Moving Average is calculated to be 42.56%.
Shares Statistics:
According to the various share statistics, CORZ traded on average about 15.19M shares per day over the past 3-months and 26533270 shares per day over the past 10 days. A total of 299.09M shares are outstanding, with a floating share count of 257.97M. Insiders hold about 13.38% of the company’s shares, while institutions hold 75.49% stake in the company. Shares short for CORZ as of 1749772800 were 46705814 with a Short Ratio of 3.07, compared to 1747267200 on 46097729. Therefore, it implies a Short% of Shares Outstanding of 46705814 and a Short% of Float of 15.83.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Core Scientific Inc (CORZ) is currently under the scrutiny of 1.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is $0.13, with high estimates of $0.13 and low estimates of $0.13.
Analysts are recommending an EPS of between $0.41 and $0.41 for the fiscal current year, implying an average EPS of $0.41. EPS for the following year is $1.61, with 1.0 analysts recommending between $1.61 and $1.61.
Revenue Estimates
According to 15 analysts, the current quarter’s revenue is expected to be $82.09M. It ranges from a high estimate of $109.6M to a low estimate of $64.13M. As of the current estimate, Core Scientific Inc’s year-ago sales were $141.1MFor the next quarter, 15 analysts are estimating revenue of $110.06M. There is a high estimate of $157.5M for the next quarter, whereas the lowest estimate is $65.22M.
A total of 16 analysts have provided revenue estimates for CORZ’s current fiscal year. The highest revenue estimate was $589.95M, while the lowest revenue estimate was $264.96M, resulting in an average revenue estimate of $427.45M. In the same quarter a year ago, actual revenue was $510.67MBased on 16 analysts’ estimates, the company’s revenue will be $866.06M in the next fiscal year. The high estimate is $1.16B and the low estimate is $515.5M.
